Replimune News

Analysts Are Bullish on Top Healthcare Stocks: Replimune Group (REPL), Merck & Company (MRK)

TipRanksMar 27 15:40

Positive Outlook for Replimune Group With Buy Rating and Increased Price Target Amidst Promising RP1 + Opdivo Therapy Trials

TipRanksFeb 15 19:26

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC)

TipRanksFeb 9 16:40

BMO Capital Keeps Their Buy Rating on Replimune Group (REPL)

TipRanksJan 9 22:25

Replimune Group (REPL) Receives a Buy From BTIG

TipRanksJan 2 22:47

BTIG Keeps Their Buy Rating on Replimune Group (REPL)

TipRanksDec 31, 2023 18:24

Balanced Outlook: Replimune's Setbacks and Potential in Clinical Trials Justify Buy Rating

TipRanksDec 7, 2023 15:59

Barclays Maintains Overweight on Replimune Group, Lowers Price Target to $13

BenzingaDec 6, 2023 19:36

Replimune Group Analyst Ratings

BenzingaDec 6, 2023 19:35

JPMorgan Adjusts Replimune Price Target to $38 From $42, Maintains Overweight Rating

MT NewswiresNov 24, 2023 21:41

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

BenzingaNov 14, 2023 07:07

Replimune Group Analyst Ratings

BenzingaNov 14, 2023 07:06

Promising Clinical Trial Results and Financial Stability Lead to Buy Rating for Replimune Group

TipRanksNov 13, 2023 19:16

Wedbush Reiterates Outperform on Replimune Group, Maintains $52 Price Target

BenzingaNov 8, 2023 22:14

Replimune Group Analyst Ratings

BenzingaNov 8, 2023 22:13

Analysts' Opinions Are Mixed on These Healthcare Stocks: Scholar Rock Holding (SRRK), Replimune Group (REPL) and Precision BioSciences (DTIL)

TipRanksNov 8, 2023 21:10

Promising Skin Cancer Treatment and Future Prospects Bolster Replimune Group's Buy Rating: An Analysis of Jonathan Chang's Recommendation

TipRanksNov 8, 2023 13:26

Analysts Conflicted on These Healthcare Names: Replimune Group (REPL), Capricor Therapeutics (CAPR) and Intellia Therapeutics (NTLA)

TipRanksOct 4, 2023 18:31

Analysts' Opinions Are Mixed on These Healthcare Stocks: Replimune Group (REPL) and Verve Therapeutics (VERV)

TipRanksAug 18, 2023 20:11

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $50

BenzingaAug 7, 2023 18:22